Evidence map›Paper›PMID 30481210›Full record

ArticlePloS one2018

Serum concentration of anti-Cytomegalovirus IgG and ischaemic stroke in patients with advanced HIV infection in Malawi.

Joseph Kamtchum-Tatuene, Zaid Al-Bayati, Henry Charles Mwandumba, Tom Solomon, Stephen E Christmas, Laura A Benjamin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Joseph Kamtchum-TatueneInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0002-1041-4202
Zaid Al-BayatiInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Henry Charles MwandumbaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Tom SolomonInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Stephen E ChristmasInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
Laura A BenjaminInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
University of Liverpool · GB

Funding

Department of Health EME/12/205/28Department of Health IS-HPU-1112-10117Department of Health RP-PG-0108-10048Medical Research Council G116/194Medical Research Council MC_PC_15096Medical Research Council MR/P020526/1Wellcome TrustWellcome Trust 089672/Z/09/AWellcome Trust 106829/Z/15/Z
6 · The paper itself

Abstract

backgroundStudies in high-income settings have shown association between Cytomegalovirus (CMV) infection and adverse cardiovascular outcome, especially in HIV infection. We aimed to study the association between serum concentration of anti-CMV IgG and ischaemic stroke in HIV-infected Malawians.

methodsOur sample was derived from a case-control stroke study in Malawi. Serum concentration of anti-CMV IgG was measured using enzyme-linked immunosorbent assay. Multivariable logistic regression was used to study the association between high concentrations of anti-CMV IgG (above the third tertile) and ischaemic stroke while adjusting for cardiovascular risk factors.

resultsOverall, 139 HIV-positive adults (48.2% women; 48 ischaemic stroke cases and 91 controls; median age: 45 years) were included. The median CD4+ count was 136 and 401 cell/mm3 (IQR: [75-278] and [230-533]) in cases and controls, respectively. High concentration of anti-CMV IgG was associated with ischaemic stroke in the univariable model (OR = 2.56 [1.23-5.34]) but not after adjusting for duration of antiretroviral therapy (ART), CD4+ count, and other cardiovascular risk factors (OR = 0.94 [0.29-3.08]). Low CD4+ count was an independent predictor of stroke. There was a negative correlation between serum concentration of anti-CMV IgG and CD4+ count (rho = -0.30, p < 0.001).

conclusionsHigh concentration of anti-CMV IgG is not independently associated with ischaemic stroke in HIV-infected Malawians. Larger cohort studies are needed to further investigate the role of humoral response to CMV in the pathophysiology of HIV-associated stroke.

Indexed as

AdultAntibodies, ViralAnti-HIV AgentsBrain IschemiaCase-Control StudiesCD4 Lymphocyte CountCoinfectionCytomegalovirusCytomegalovirus InfectionsFemaleHIV InfectionsHumansImmunoglobulin GImmunosuppression TherapyMalawiMaleAntibodies, ViralAnti-HIV AgentsImmunoglobulin G

Identifiers

PMID30481210
PMCPMC6258562
OpenAlexW2902298917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.